Achieve recognition of all radiotherapy professions
Adjuvant and concurrent temozolomide for 1p/19q non-co-deleted anaplastic glioma (CATNON; EORTC study 26053-22054): second interim analysis of a randomised, open-label, phase III study - Read It
Phase III Randomised Trial of Prophylactic Cranial Irradiation With or Without Hippocampus Avoidance in SCLC (NCT01780675) - Read It
Neoadjuvant durvalumab with or without stereotactic body radiotherapy in patients with early-stage non-small-cell lung cancer: a single-centre, randomised phase 2 trial - Read It
The HILUS-Trial-a Prospective Nordic Multicenter Phase II Study of Ultracentral Lung Tumours Treated With Stereotactic Body Radiotherapy - Read It Corner
Use of Total Neoadjuvant Therapy for Locally Advanced Rectal Cancer: Initial Results From the Pembrolizumab Arm of a Phase II Randomised Clinical Trial - Read It
Stereotactic body radiotherapy versus conventional external beam radiotherapy in patients with painful spinal metastases: an open-label, multicentre, randomised, controlled, phase II/III trial Read It
Corner Editor: Philippe Lambin
Corner Editor: Dirk de Ruysscher